Kathleen Jagodnik

Dr. Kathleen Jagodnik

Bar-Ilan University, Israel
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AKAlexandra B Keenan
Alexandra B Keenan
DTDenis Torre
Denis Torre
ALAlexander Lachmann
Alexander Lachmann
ALAriel K Leong
Ariel K Leong
MWMegan L Wojciechowicz
Megan L Wojciechowicz
AMAvi Ma’ayan
Avi Ma’ayan
Identifying the transcription factors (TFs) responsible for observed changes in gene expression is an important step in understanding gene regulatory networks. ChIP-X Enrichment Analysis 3 (ChEA3) is a transcription factor enrichment analysis tool that ranks TFs associated with user-submitted gene sets. The ChEA3 background database contains a collection of gene set libraries generated from multiple sources including TF–gene co-expression from RNA-seq studies, TF–target associations from ChIP-seq experiments, and TF–gene co-occurrence computed from crowd-submitted gene lists. Enrichment results from these distinct sources are integrated to generate a composite rank that improves the prediction of the correct upstream TF compared to ranks produced by individual libraries. We compare ChEA3 with existing TF prediction tools and show that ChEA3 performs better. By integrating the ChEA3 libraries, we illuminate general transcription factor properties such as whether the TF behaves as an activator or a repressor. The ChEA3 web-server is available from https://amp.pharm.mssm.edu/ChEA3.

1 March 2021 in Patterns
Verified
Journal Article
Open access
DCDaniel J.B. Clarke
Daniel J.B. Clarke
MJMinji Jeon
Minji Jeon
DSDaniel J. Stein
Daniel J. Stein
NMNicole Moiseyev
Nicole Moiseyev
EKEryk Kropiwnicki
Eryk Kropiwnicki
AMAvi Ma’ayan
Avi Ma’ayan
Jupyter Notebooks have transformed the communication of data analysis pipelines by facilitating a modular structure that brings together code, markdown text, and interactive visualizations. Here, we extended Jupyter Notebooks to broaden their accessibility with Appyters. Appyters turn Jupyter Notebooks into fully functional standalone web-based bioinformatics applications. Appyters present to users an entry form enabling them to upload their data and set various parameters for a multitude of data analysis workflows. Once the form is filled, the Appyter executes the corresponding notebook in the cloud, producing the output without requiring the user to interact directly with the code. Appyters were used to create many bioinformatics web-based reusable workflows, including applications to build customized machine learning pipelines, analyze omics data, and produce publishable figures. These Appyters are served in the Appyters Catalog at https://appyters.maayanlab.cloud. In summary, Appyters enable the rapid development of interactive web-based bioinformatics applications.

19 April 2010 in Journal of Biomechanics
Verified
Journal Article
Closed access
Kathleen JagodnikKathleen Jagodnik
Kathleen Jagodnik
ABAntonie J. Van Den Bogert
Antonie J. Van Den Bogert

1 January 2021 in Database: The Journal of Biological Databases and Curation
Verified
Journal Article
Open access
PDF file
EKEryk Kropiwnicki
Eryk Kropiwnicki
JEJohn E Evangelista
John E Evangelista
DSDaniel J Stein
Daniel J Stein
DCDaniel J B Clarke
Daniel J B Clarke
ALAlexander Lachmann
Alexander Lachmann
AMAvi Ma’ayan
Avi Ma’ayan
Understanding the underlying molecular and structural similarities between seemingly heterogeneous sets of drugs can aid in identifying drug repurposing opportunities and assist in the discovery of novel properties of preclinical small molecules. A wealth of information about drug and small molecule structure, targets, indications and side effects; induced gene expression signatures; and other attributes are publicly available through web-based tools, databases and repositories. By processing, abstracting and aggregating information from these resources into drug set libraries, knowledge about novel properties of drugs and small molecules can be systematically imputed with machine learning. In addition, drug set libraries can be used as the underlying database for drug set enrichment analysis. Here, we present Drugmonizome, a database with a search engine for querying annotated sets of drugs and small molecules for performing drug set enrichment analysis. Utilizing the data within Drugmonizome, we also developed Drugmonizome-ML. Drugmonizome-ML enables users to construct customized machine learning pipelines using the drug set libraries from Drugmonizome. To demonstrate the utility of Drugmonizome, drug sets from 12 independent SARS-CoV-2 in vitro screens were subjected to consensus enrichment analysis. Despite the low overlap among these 12 independent in vitro screens, we identified common biological processes critical for blocking viral replication. To demonstrate Drugmonizome-ML, we constructed a machine learning pipeline to predict whether approved and preclinical drugs may induce peripheral neuropathy as a potential side effect. Overall, the Drugmonizome and Drugmonizome-ML resources provide rich and diverse knowledge about drugs and small molecules for direct systems pharmacology applications. Database URL: https://maayanlab.cloud/drugmonizome/.

15 November 2016 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
GGGregory W. Gundersen
Gregory W. Gundersen
Kathleen JagodnikKathleen Jagodnik
Kathleen Jagodnik
HWHolly Woodland
Holly Woodland
NFNicholas F. Fernandez
Nicholas F. Fernandez
KSKevin Sani
Kevin Sani
AMAvi Ma’ayan
Avi Ma’ayan
Background: Genome-wide gene expression profiling of mammalian cells is becoming a staple of many published biomedical and biological research studies. Such data is deposited into data repositories such as the Gene Expression Omnibus (GEO) for potential reuse. However, these repositories currently do not provide simple interfaces to systematically analyze collections of related studies. Results: Here we present GENE Expression and Enrichment Vector Analyzer (GEN3VA), a web-based system that enables the integrative analysis of aggregated collections of tagged gene expression signatures identified and extracted from GEO. Each tagged collection of signatures is presented in a report that consists of heatmaps of the differentially expressed genes; principal component analysis of all signatures; enrichment analysis with several gene set libraries across all signatures, which we term enrichment vector analysis; and global mapping of small molecules that are predicted to reverse or mimic each signature in the aggregate. We demonstrate how GEN3VA can be used to identify common molecular mechanisms of aging by analyzing tagged signatures from 244 studies that compared young vs. old tissues in mammalian systems. In a second case study, we collected 86 signatures from treatment of human cells with dexamethasone, a glucocorticoid receptor (GR) agonist. Our analysis confirms consensus GR target genes and predicts potential drug mimickers. Conclusions: GEN3VA can be used to identify, aggregate, and analyze themed collections of gene expression signatures from diverse but related studies. Such integrative analyses can be used to address concerns about data reproducibility, confirm results across labs, and discover new collective knowledge by data reuse. GEN3VA is an open-source web-based system that is freely available at: http://amp.pharm.mssm.edu/gen3va.

24 May 2016 in IEEE Transactions on Human-Machine Systems
Verified
Journal Article
Closed access
Kathleen JagodnikKathleen Jagodnik
Kathleen Jagodnik
PTPhilip S. Thomas
Philip S. Thomas
ABAntonie J. van Den Bogert
Antonie J. van Den Bogert
MBMichael S. Branicky
Michael S. Branicky
RKRobert F. Kirsch
Robert F. Kirsch
High-level spinal cord injury (SCI) in humans causes paralysis below the neck. Functional electrical stimulation (FES) technology applies electrical current to nerves and muscles to restore movement, and controllers for upper extremity FES neuroprostheses calculate stimulation patterns to produce desired arm movement. However, currently available FES controllers have yet to restore natural movements. Reinforcement learning (RL) is a reward-driven control technique; it can employ user-generated rewards, and human preferences can be used in training. To test this concept with FES, we conducted simulation experiments using computer-generated “pseudo-human” rewards. Rewards with varying properties were used with an actor-critic RL controller for a planar two-degree-of-freedom biomechanical human arm model performing reaching movements. Results demonstrate that sparse, delayed pseudo-human rewards permit stable and effective RL controller learning. The frequency of reward is proportional to learning success, and human-scale sparse rewards permit greater learning than exclusively automated rewards. Diversity of training task sets did not affect learning. Long-term stability of trained controllers was observed. Using human-generated rewards to train RL controllers for upper-extremity FES systems may be useful. Our findings represent progress toward achieving human-machine teaming in control of upper-extremity FES systems for more natural arm movements based on human user preferences and RL algorithm learning capabilities.